Prescription Products
This information is intended for Canadian residents.
Sanofi is a leader in the global pharmaceutical market, with an extensive line of prescription medicines. Links to comprehensive information about our pharmaceutical products are listed below, most frequently in the form of a product monograph.
This information has been approved by Health Canada and should be read and discussed in consultation with a health care professional.
Diabetes
Admelog™ and Admelog™ SoloSTAR®
(insuline lispro injectable)
Rare diseases
Aldurazyme®
(laronidase)
Diabetes
AllStar® Pro
Rare blood disorders
Alprolix®
(coagulation factor IX (recombinant), Fc fusion protein)
Diabetes
Apidra®
(insulin glulisine)
Other
Arava®
(leflunomide)
Neurology
Aubagio®
(teriflunomide)
Cardiovascular diseases
Avalide®
(irbesartan, hydrochlorothiazide)
Cardiovascular diseases
Avapro®
(irbesartan)
Rare blood disorders
Cablivi™
(caplacizumab)
Other
Calcimar®
(calcitonin-salmon)
Oncology
Caprelsa®
(vandetanib)
Rare diseases
Cerdelga®
(eliglustat)
Rare diseases
Cerezyme®
(imiglucerase)
Oncology
Clolar®
(clofarabine for injection)
Other
Cyclomen®
(danazol)
Immunology
Dupixent®
(dupilumab)
Rare blood disorders
Eloctate®
(antihemophilic factor (recombinant BDD), Fc fusion protein )
Rare diseases
Fabrazyme®
(agalsidase beta)
Oncology
Fasturtec®
(rasburicase)
Other
Ferrlecit®
(sodium ferric gluconate)
Other
Flagyl®
(metronidazole)
Other
Flagystatin®
(metronidazole, nystatin)
Oncology
Fludara®
(fludarabine phosphate)
Diabetes
Glucophage®
(metformin hydrochloride)
Other
Imovane®
(zopiclone)
Oncology
Jevtana®
(cabazitaxel)
Diabetes
JuniorSTAR®
Other
Kayexalate®
(sodium polystyrene sulfonate)
Immunology
Kevzara®
(sarilumab)
Diabetes
Lantus®
(insuline glargine)
Cardiovascular diseases
Lasix® Oral Solution
(furosemide)
Cardiovascular diseases
Lasix® Special
(furosemide)
Neurology
Lemtrada®
(alemtuzumab)
Oncology
Libtayo™
(cemiplimab)
Other
Lovenox® / Lovenox® HP
(enoxaparin sodium)
Oncology
MabCampath®
(alemtuzumab)
Other
Mersyndol® with Codeine
(acetaminophen, codeine phosphate, doxylamine succinate)
Other
Mozobil®
(plerixafor injection)
Cardiovascular diseases
Multaq®
(dronedarone tablets)
Rare diseases
Myozyme®
(alglucosidase alfa)
Other
Nalcrom®
(sodium cromoglycate)
Rare diseases
Nexviazyme™
(avalglucosidase alfa for injection)
Cardiovascular diseases
Nitrolingual® Pumpspray
Trademark of G. Pohl-Boskamp GmbH & Co. Commercialized in Canada by sanofi-aventis. (nitroglycerin)
Other
Pediapred®
(prednisolone sodium phosphate)
Other
Plaquenil®
(hydroxychloroquine sulfate)
Cardiovascular diseases
Plavix®
(clopidogrel bisulfate)
Cardiovascular diseases
Praluent®
(alirocumab)
Other
Primaquine®
(primaquine phosphate)
Other
Renagel®
(sevelamer hydrochloride tablets)
This information is intended for Canadian residents. By clicking on the links in the banners above and below this page, you will be leaving Sanofi Canada’s website. The links may contain information not intended for Canadian residents. If you wish to continue viewing information intended for Canadian residents, please remain on this page.